The application of topical tacrolimus in vesicular pemphigoid [17]

British Journal of Dermatology

Volumn 150, Issue 3, 2004, Pages 622-623

  Chuh, A A T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CLOBETASOL PROPIONATE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MINOCYCLINE; PREDNISOLONE; STEROID; TACROLIMUS;

AGED; CASE REPORT; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHILIA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOFLUORESCENCE; LETTER; LONG TERM CARE; MALE; PEMPHIGOID; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SKIN MANIFESTATION; VESICULAR PEMPHIGOID;

ADMINISTRATION, TOPICAL; AGED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; PEMPHIGOID, BULLOUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 1842454216     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05835.x     Document Type: Letter

References (10)

1. Mutasim DF. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging 2003; 20: 663-81.
2. Khumalo N, Kirtschig G, Middleton P et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2003; CD002292.
3. Bean SF, Michel B, Furey N et al. Vesicular pemphigoid. Arch Dermatol 1976; 112: 1402-4.
4. Gruber GG, Owen LG, Callen JP. Vesicular pemphigoid. J Am Acad Dermatol 1980; 3: 619-22.
5. Hayakawa K, Shimizu H, Amagai M et al. Vesicular pemphigoid - ultrastructural and immunoelectron microscopic study. Dermatologica 1989; 178: 213-16.
6. Requena L, Vazquez F, Sanchez Yus E. Vesicular pemphigoid. Cutis 1991; 47: 333-6.
7. Chu J, Bradley M, Marinkovich MP. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. Arch Dermatol 2003; 139: 813-15.
8. Liu Z, Diaz LA. Bullous pemphigoid: end of the century overview. J Dermatol 2001; 28: 647-50.
9. Giomi B, Caproni M, Calzolari A et al. Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid. J Dermatol Sci 2002; 30: 116-28.
10. Feliciani C, Toto P, Mohammad Pour S et al. A Th2-like cytokine response is involved in bullous pemphigoid: the role of IL-4 and IL-5 in the pathogenesis of the disease. Int J Immunopathol Pharmacol 1999; 12: 55-61.